Leon L. Hsieh

Leon L. Hsieh

Auto-generated profile, based on publicly available information

Leon L. Hsieh

Department of Microbiology, New York University, Grossman School of Medicine, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2018 in Science
Verified
Journal Article
Closed access
PDF file
CWCraig Wilen
Craig Wilen
SLSanghyun Lee
Sanghyun Lee
LHLeon L. Hsieh
Leon L. Hsieh
RORobert C. Orchard
Robert C. Orchard
CDChandni Desai
Chandni Desai
HVHerbert W. Virgin
Herbert W. Virgin
Aiding and abetting norovirus disease: Norovirus is highly infectious and usually causes transient, acute disease. In some individuals, norovirus persists and is associated with inflammatory bowel disorders. While investigating the cell tropism for murine norovirus, Wilen et al. discovered that a rare cell type, tuft cells, carrying the CD300lf receptor were the virus's specific target. Tuft cells proliferate in response to the type 2 cytokines interleukin-4 and interleukin-25, which thereby amplify norovirus infection. Moreover, infected tuft cells are resistant to immune clearance. This effect may explain the associated persistent disease symptoms that humans can suffer. Science , this issue p. 204

7 September 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CNChristopher A. Nelson
Christopher A. Nelson
CWCraig B. Wilen
Craig B. Wilen
YDYa-Nan Dai
Ya-Nan Dai
RORobert C. Orchard
Robert C. Orchard
AKArthur S. Kim
Arthur S. Kim
DFDaved H. Fremont
Daved H. Fremont
Murine norovirus (MNoV) is closely related to human norovirus (HNoV), an infectious agent responsible for acute gastroenteritis worldwide. Here we report the X-ray crystal structure of the dimeric MNoV VP1 protruding (P) domain in complex with its cellular receptor CD300lf. CD300lf binds the P domain with a 2:2 stoichiometry, engaging a cleft between the AB and DE loops of the P2 subdomain at a site that overlaps the epitopes of neutralizing antibodies. We also identify that bile acids are cofactors enhancing MNoV cell-binding and infectivity. Structures of CD300lf–P domain in complex with glycochenodeoxycholic acid (GCDCA) and lithocholic acid (LCA) reveal two bile acid binding sites at the P domain dimer interface distant from receptor binding sites. The structural determinants for receptor and bile acid binding are supported by numerous biophysical assays utilizing interface residue mutations. We find that the monomeric affinity of CD300lf for the P domain is low and is divalent cation dependent. We have also determined the crystal structure of CD300lf in complex with phosphocholine, revealing that MNoV engages its receptor in a manner mimicking host ligands including similar metal coordination. Docking of the cocomplex structures onto a cryo-EM–derived model of MNoV suggests that each virion can make multiple CD300lf engagements, and thus, infection may be driven by the avidity of cell surface clustered CD300lf. These studies identify multiple potential modulators of norovirus infection that may act to regulate the interaction between the viral capsid P domain and its cognate cellular receptor.

6 April 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
VGVincent R. Graziano
Vincent R. Graziano
FWForrest C. Walker
Forrest C. Walker
EKElizabeth A. Kennedy
Elizabeth A. Kennedy
JWJin Wei
Jin Wei
KEKhalil Ettayebi
Khalil Ettayebi
CWCraig Wilen
Craig Wilen
Murine norovirus (MNoV) is an important model of human norovirus (HNoV) and mucosal virus infection more broadly. Viral receptor utilization is a major determinant of cell tropism, host range, and pathogenesis. The bona fide receptor for HNoV is unknown. Recently, we identified CD300lf as a proteinaceous receptor for MNoV. Interestingly, its paralogue CD300ld was also sufficient for MNoV infection in vitro. Here we explored whether CD300lf is the sole physiologic receptor in vivo and whether HNoV can use a CD300 ortholog as an entry receptor. We report that both CD300ld and CD300lf are sufficient for infection by diverse MNoV strains in vitro. We further demonstrate that CD300lf is essential for both oral and parenteral MNoV infection and to elicit anti-MNoV humoral responses in vivo. In mice deficient in STAT1 signaling, CD300lf is required for MNoV-induced lethality. Finally, we demonstrate that human CD300lf (huCD300lf) is not essential for HNoV infection, nor does huCD300lf inhibit binding of HNoV virus-like particles to glycans. Thus, we report huCD300lf is not a receptor for HNoV. Human norovirus is the leading cause of non-bacterial gastroenteritis causing up to 200,000 deaths each year. How human norovirus enters cells is unknown. Because human norovirus is difficult to grow in the laboratory and in small animals, we use mouse or murine norovirus as a model system. We recently discovered that murine norovirus can use the either CD300ld or CD300lf as a receptor in vitro. We also showed that CD300lf deficient mice were resistant to oral challenge with a single virus strain. Here we determined that CD300lf is essential for infection of diverse murine norovirus strains in cell lines and in mice with normal immune systems demonstrating it’s the primary physiologic receptor for diverse murine norovirus strains independent of infection route. Finally, we demonstrated that human CD300lf is not the elusive proteinaceous receptor for human norovirus.

21 May 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
LHLeon L. Hsieh
Leon L. Hsieh
ETElizabeth A. Thompson
Elizabeth A. Thompson
NJNirvani P. Jairam
Nirvani P. Jairam
KRKaterina Roznik
Katerina Roznik
AFAlexis Figueroa
Alexis Figueroa
ACAndrea L. Cox
Andrea L. Cox
Severe COVID-19 presents with a distinct immunological profile, characterized by elevated neutrophil and reduced lymphocyte counts, seen commonly in fungal and bacterial infections. This study demonstrates that patients hospitalized with COVID-19 show evidence of neutrophil degranulation and have increased expression of neutrophil surface lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a marker of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Both early LOX-1 and programmed death-ligand 1 (PD-L1) expression on neutrophils were associated with development of severe disease. To determine whether tissue damage or inflammation is required to induce PMN-MDSCs or whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly activates neutrophils to become PMN-MDSCs, we incubated healthy human neutrophils with SARS-CoV-2. SARS-CoV-2 rapidly induced LOX-1 surface expression in healthy neutrophils independent of productive infection. LOX-1 induction was dependent on granule exocytosis and promoted up-regulation of reactive oxygen species, CD63, and PD-L1, enabling LOX-1 + neutrophils to suppress autologous T cell proliferation in vitro. These results support a role for PMN-MDSCs in mediating severe COVID-19, and inhibition of PD-L1 represents a potential therapeutic strategy for enhancing the immune response in acute SARS-CoV-2 infection.

16 October 2024 in mBio
Verified
Journal Article
Open access
LHLeon L. Hsieh
Leon L. Hsieh
MLMonika Looney
Monika Looney
AFAlexis Figueroa
Alexis Figueroa
GMGuido Massaccesi
Guido Massaccesi
GSGeorgia Stavrakis
Georgia Stavrakis
ACAndrea L. Cox
Andrea L. Cox
The pathogenesis of COVID-19 is associated with a hyperinflammatory immune response. Monocytes and macrophages play a central role in this hyperinflammatory response to SARS-CoV-2. NLRP3 inflammasome activation has been observed in monocytes of patients with COVID-19, but the mechanism and consequences of inflammasome activation require further investigation. In this study, we inoculated a macrophage-like THP-1 cell line, primary differentiated human nasal epithelial cell (hNEC) cultures, and primary monocytes with SARS-CoV-2. We found that the activation of the NLRP3 inflammasome in macrophages does not rely on viral replication, receptor-mediated entry, or actin-dependent entry. SARS-CoV-2 productively infected hNEC cultures without triggering the production of inflammasome cytokines IL-18 and IL-1β. Importantly, these cytokines did not inhibit viral replication in hNEC cultures. SARS-CoV-2 inoculation of primary monocytes led to inflammasome activation and induced a macrophage phenotype in these cells. Monocytic cells from bronchoalveolar lavage (BAL) fluid, but not from peripheral blood, of patients with COVID-19, showed evidence of inflammasome activation, expressed the proinflammatory marker CD11b, and displayed oxidative burst. These findings highlight the central role of activated macrophages, as a result of direct viral sensing, in COVID-19 and support the inhibition of IL-1β and IL-18 as potential therapeutic strategies to reduce immunopathology without increasing viral replication. IMPORTANCE: Inflammasome activation is associated with severe COVID-19. The impact of inflammasome activation on viral replication and mechanistic details of this activation are not clarified. This study advances our understanding of the role of inflammasome activation in macrophages by identifying TLR2, NLRP3, ASC, and caspase-1 as dependent factors in this activation. Further, it highlights that SARS-CoV-2 inflammasome activation is not a feature of nasal epithelial cells but rather activation of bystander macrophages in the airway. Finally, we demonstrate that two pro inflammatory cytokines produced by inflammasome activation, IL-18 and IL-1β, do not restrict viral replication and are potential targets to ameliorate pathological inflammation in severe COVID-19.

23 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Cathy W. S. ChenCathy W. S. Chen
Cathy W. S. Chen
LHLeon L. Hsieh
Leon L. Hsieh
BCBetty X.Y. Chu
Betty X.Y. Chu
Objectives: Enteroviruses pose a substantial public health challenge in Taiwan, often leading to increased healthcare visits. This study utilizes Taiwan CDC databases to analyse weekly enterovirus case data from emergency departments (EDs), as well as outpatient and inpatient settings. The objectives are to understand infection patterns through model fitting, forecast future visits for proactive epidemic management, and improve forecast accuracy by incorporating holiday effects. This approach enhances the reliability of predictions, supporting timely and effective surveillance and early detection of significant case surges. Methods: This study divides the time series data into an in-sample period (2016—2023) and an out-of-sample period covering weeks 1 to 27 in 2024. Using an expanding window approach, the analysis applies Bayesian structural time series (BSTS) models, exponential smoothing, and random forest to forecast one-week-ahead cases over the 27 weeks in 2024. The study evaluates forecast accuracy using five key metrics and identifies significant surges in cases by detecting values that exceed the 95% prediction intervals, enhancing anomaly detection. Results: The results demonstrate that BSTS models, which incorporate trends, seasonal variations, summer, and Lunar New Year holiday effects, achieve superior forecasting accuracy. Specifically, by accounting for the Lunar New Year holiday within the out-of-sample period, the models attain mean absolute percentage error (MAPE) values of 6.509% for non-ED visits and 12.645% for ED visits. Conclusions: The BSTS model effectively addresses nonlinearity and non-stationarity and adapts well to structural changes. This study highlights the importance of holiday adjustments, particularly for the Lunar New Year, in improving forecast accuracy during periods of unusual healthcare demand. These adjustments enhance the BSTS model performance for predicting irregular healthcare service demand.